BINDO, FRANCESCO
BINDO, FRANCESCO
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.0 secondi).
Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation
2021 A. Gramegna, M. Contarini, F. Bindo, S. Aliberti, F. Blasi
Respiratory failure in COVID-19: a patient's perspective and clinical cases
2021 F. Amati, A. Vigni, S. Misuraca, F. Bindo, A. Gramegna, A. Voza, F. Blasi, S. Aliberti
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
2021 M. Oriano, A. Gramegna, F. Amati, A. D’Adda, M. Gaffuri, M. Contoli, F. Bindo, E. Simonetta, C. Di Francesco, M. Santambrogio, G. Sotgiu, F. Blasi, S. Aliberti
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation | 1-gen-2021 | Gramegna, AndreaBindo, FrancescoAliberti, StefanoBlasi, Francesco + | Article (author) | - | |
| Respiratory failure in COVID-19: a patient's perspective and clinical cases | 1-gen-2021 | Misuraca, SofiaBindo, FrancescoGramegna, AndreaBlasi, Francesco + | Book Part (author) | - | |
| T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis | 1-lug-2021 | M. OrianoA. GramegnaM. GaffuriF. BindoE. SimonettaF. BlasiS. Aliberti + | Article (author) | - |